Company Profile
Galapagos NV Stock Price, News & Catalysts
- Ticker:
- GLPG
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Belgium
Stock performance
27.73 USD (-3.75%)
Close
Last updated: May 7, 2026
1.83B USD
Market cap
Why the stock is moving
Current closing-price context is not available for GLPG.
Company overview
Business overview
Galapagos is a biotechnology company with a long history in immunology and inflammatory disease, and it has also redefined itself around partnership and pipeline strategy. Its story is shaped by platform science, corporate evolution, and a global footprint.
Geographic Base and Sector Classification
Galapagos is headquartered in Belgium and listed on NASDAQ. It sits in global specialty biotechnology.
Business Model Characteristics
The company depends on pipeline progress, partnership strategy, and the ability to convert its scientific base into durable value. Investors watch clinical updates, business development, and portfolio direction.
Position Within the Biotechnology Landscape
Galapagos occupies a global immunology-biotech niche. The stock is driven by whether the company can keep its innovation engine relevant after strategic shifts.
Future catalysts
- Galapagos’s catalysts are oncology and cell-therapy repositioning, plus any update that clarifies how much value remains in the post-reshape platform. The market will care more about strategic direction than about broad pipeline optionality.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Galapagos NV (GLPG)?
Galapagos NV (GLPG) most recently closed at 27.73 USD, a -3.75% move versus the previous session.
What is the market cap of Galapagos NV (GLPG)?
Galapagos NV currently has a market capitalization of 1.83B USD on BioPharmSignal.
What does Galapagos NV do?
Galapagos is a biotechnology company with a long history in immunology and inflammatory disease, and it has also redefined itself around partnership and pipeline strategy. Its story is shaped by platform science, corporate evolution, and a global footprint.
On which exchange is GLPG stock listed?
Galapagos NV (GLPG) is associated with NASDAQ, Belgium, Biopharma.
What is Galapagos?
Galapagos’s catalysts are oncology and cell-therapy repositioning, plus any update that clarifies how much value remains in the post-reshape platform.
Which conditions is Galapagos NV targeting with Galapagos?
Galapagos NV is associated with oncology, immunology based on its company overview and current catalyst commentary.
How does Galapagos NV describe recent progress with Galapagos?
Galapagos’s catalysts are oncology and cell-therapy repositioning, plus any update that clarifies how much value remains in the post-reshape platform.
What future catalysts are investors watching for Galapagos NV?
Galapagos’s catalysts are oncology and cell-therapy repositioning, plus any update that clarifies how much value remains in the post-reshape platform. The market will care more about strategic direction than about broad pipeline optionality.